The choice of tocolytic drugs for preterm labor-comparison of COX-2 inhibitor and magnesium sulfate

Journal of Obstetrics and Gynaecology Research

Volumn 34, Issue 3, 2008, Pages 439-440

  Wang, Peng Hui ^a   Cheng, Ming Huei ^a   Lee, Wen Ling ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MAGNESIUM SULFATE; ROFECOXIB; UTERUS SPASMOLYTIC AGENT;

BODY WEIGHT; BRAIN HEMORRHAGE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GESTATIONAL AGE; HUMAN; LETTER; NECROTIZING ENTEROCOLITIS; PERINATAL MORTALITY; PREMATURE LABOR; PRENATAL DISORDER; RESPIRATORY DISTRESS; UNSPECIFIED SIDE EFFECT;

CYCLOOXYGENASE 2 INHIBITORS; FEMALE; HUMANS; MAGNESIUM SULFATE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; TOCOLYTIC AGENTS;

EID: 45149104292     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00785.x     Document Type: Letter

References (5)

1. Borna S, Saeidi FM. Celecoxib versus magnesium sulfate to arrest preterm labor: randomized trial. J Obstet Gynaecol Res 2007 33 : 631 634.
2. Chou MM. Litigation in obstetrics: a lesson learnt and a lesson to share. Taiwanese J Obstet Gynecol 2006 45 : 1 9.
3. King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005 2 DM, Ammann C. Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front Biosci 2007 12 : 1329 1343.
4. Loe SM, Sanchez-Ramos L, Kaunitz AM. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol 2005 106 : 173 179.
5. Groom KM, Shennan AH, Jones BA, Seed P, Bennett PR. TOCOX - a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. BJOG 2005 112 : 725 730.